B. Riley Financial Inc. lessened its holdings in Sensus Healthcare Inc (NASDAQ:SRTS) by 78.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,300 shares of the company’s stock after selling 82,494 shares during the period. B. Riley Financial Inc. owned about 0.17% of Sensus Healthcare worth $111,000 as of its most recent SEC filing.
Separately, Maxim Group raised their target price on shares of Sensus Healthcare from $6.50 to $7.50 and gave the company a “buy” rating in a research note on Friday, November 3rd.
In related news, insider Kalman Fishman sold 4,183 shares of the firm’s stock in a transaction on Friday, October 27th. The shares were sold at an average price of $6.00, for a total transaction of $25,098.00. Following the completion of the sale, the insider now directly owns 960,649 shares of the company’s stock, valued at approximately $5,763,894. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Richard Golin sold 7,334 shares of the firm’s stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $6.00, for a total transaction of $44,004.00. Following the sale, the insider now directly owns 971,509 shares of the company’s stock, valued at $5,829,054. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 31,260 shares of company stock valued at $187,560. Company insiders own 41.70% of the company’s stock.
Sensus Healthcare Inc (NASDAQ SRTS) opened at $5.19 on Thursday. Sensus Healthcare Inc has a one year low of $3.38 and a one year high of $6.25.
WARNING: “B. Riley Financial Inc. Cuts Stake in Sensus Healthcare Inc (SRTS)” was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thestockobserver.com/2017/12/07/b-riley-financial-inc-cuts-stake-in-sensus-healthcare-inc-srts.html.
Sensus Healthcare Company Profile
Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.
Want to see what other hedge funds are holding SRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sensus Healthcare Inc (NASDAQ:SRTS).
Receive News & Ratings for Sensus Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.